首页> 外文期刊>中国癌症研究(英文版) >THE CLINICAL SIGNIFICANCE OF MULTIDRUG RESISTANCE GENE (mdr1) EXPRESSION IN ACUTE LEUKEMIA
【24h】

THE CLINICAL SIGNIFICANCE OF MULTIDRUG RESISTANCE GENE (mdr1) EXPRESSION IN ACUTE LEUKEMIA

机译:急性白血病中多药耐药基因(mdr1)表达的临床意义

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To study the clinical significance of multidrug resistance gene expression in acute leukemia.Methods: The relationships between drug resistance of leukemia cells and prognosis, multidrug resistance gene (mdr1) were examined in 85 patients with acute leukemia and 20 normal controls by reverse transcriptase polymerase chain reaction (RT-PCR). Results: The mdr1 positive rate in untreated group was 44.7 %. The complete remission (CR) rate of mdr1 positive patients (23.9 %) was significantly lower than that of mdr1 negative patients(88.5 %) (P<0.005). The mdr1 expression level in relapsedrefractory group was higher than that of CR group. A gradually increased mdr1 mRNA level in CR patients indicated early relapse. Conclusion: The mdr1 positive rate in normal control and long-term survival patients was very low. The mdr1 expression was correlated with French-American-British Cooperative Group (FAB)classification. The mdr1 expression level was correlated with chemotherapeutic effect and prognosis. It is an unfavorable prognostic factor for patients with acute leukemia.
机译:目的:探讨急性白血病多药耐药基因表达的临床意义。方法:采用逆转录酶联用法检测85例急性白血病患者和20例正常对照者的白血病细胞耐药性与预后的关系。聚合酶链反应(RT-PCR)。结果:未治疗组的mdr1阳性率为44.7%。 mdr1阳性患者的完全缓解(CR)率(23.9%)显着低于mdr1阴性患者的完全缓解(88.5%)(P <0.005)。复发难治组mdr1表达水平高于CR组。 CR患者的mdr1 mRNA水平逐渐升高表明早期复发。结论:正常对照和长期生存患者的mdr1阳性率很低。 mdr1的表达与法裔美英合作组(FAB)分类相关。 mdr1表达水平与化疗效果和预后相关。它是急性白血病患者不利的预后因素。

著录项

  • 来源
    《中国癌症研究(英文版)》 |1998年第1期|59-62|共4页
  • 作者单位

    The Second Affiliated Hospital,Hebei Medical University, Shijiazhuang 050000;

    The Second Affiliated Hospital,Hebei Medical University, Shijiazhuang 050000;

    Molecular Biology Department, Hebei Medical University, Shijiazhuang 050000;

    The Second Affiliated Hospital,Hebei Medical University, Shijiazhuang 050000;

    The Second Affiliated Hospital,Hebei Medical University, Shijiazhuang 050000;

    The Second Affiliated Hospital,Hebei Medical University, Shijiazhuang 050000;

    The Second Affiliated Hospital,Hebei Medical University, Shijiazhuang 050000;

    The Second Affiliated Hospital,Hebei Medical University, Shijiazhuang 050000;

    The Second Affiliated Hospital,Hebei Medical University, Shijiazhuang 050000;

    Molecular Biology Department, Hebei Medical University, Shijiazhuang 050000;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肿瘤学;
  • 关键词

    Leukemia; Drug resistance; Gene expression; Polymerase chain reaction;

    机译:白血病;耐药性;基因表达;聚合酶链反应;
  • 入库时间 2022-08-19 03:43:16
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号